| Early goal-directed therapy in severe sepsis and septic shock: a contemporary review of the literature. | |
| | |
MedLine Citation:
|
PMID: 18443478 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE OF REVIEW: Aggressive approaches to acute diseases such as acute myocardial infarction, trauma, and stroke have improved outcomes. Early goal-directed therapy for severe sepsis and septic shock represents a similar approach. An analysis of the literature assessing external validity and generalizability of this intervention is lacking. RECENT FINDINGS: Eleven peer-reviewed publications (1569 patients) and 28 abstracts (4429 patients) after the original early goal-directed therapy study were identified from academic, community and international settings. These publications total 5998 patients (3042 before and 2956 after early goal-directed therapy). The mean age, sex, APACHE II scores and mortality were similar across all studies. The mean relative and absolute risk reduction was 0.46 +/- 26% and 20.3 +/- 12.7%, respectively. These findings are superior to the original early goal-directed therapy trial which showed figures of 34% and 16%, respectively. A consistent and similar decrease in healthcare resource consumption was also found. SUMMARY: Early goal-directed therapy modulates systemic inflammation and results in significant reductions in morbidity, mortality, and healthcare resource consumption. Early goal-directed therapy has been externally validated and is generalizable across multiple healthcare settings. Because of these robust findings, further emphasis should be placed on overcoming logistical, institutional, and professional barriers to implementation which can save the life of one of every six patients presenting with severe sepsis and septic shock. |
| | |
Authors:
|
Emanuel P Rivers; Victor Coba; Melissa Whitmill |
Related Documents
:
|
3729098 - Conjunctival oxygen tension monitoring during helicopter transport of critically ill pa... 1866008 - Preherpetic neuralgia. 22082598 - Blepharospasm in a patient with pontine capillary telangiectasia. 9605378 - Effect of an endotoxin-removing column containing immobilized polymyxin b fiber in a pa... 2245298 - Myelopathy associated with human t cell lymphotropic virus type i (htlv-i) in natal, so... 11689218 - Age-dependence of risk factors for carotid stenosis: an observational study among candi... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Current opinion in anaesthesiology Volume: 21 ISSN: 0952-7907 ISO Abbreviation: Curr Opin Anaesthesiol Publication Date: 2008 Apr |
Date Detail:
|
Created Date: 2008-04-29 Completed Date: 2008-05-13 Revised Date: 2008-09-08 |
Medline Journal Info:
|
Nlm Unique ID: 8813436 Medline TA: Curr Opin Anaesthesiol Country: United States |
Other Details:
|
Languages: eng Pagination: 128-40 Citation Subset: IM |
Affiliation:
|
Department of Emergency Medicine, Henry Ford Health Systems, Detroit, Michigan 48202, USA. erivers1@hfhs.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
APACHE Animals Hemodynamics Humans Sepsis / physiopathology, therapy* Shock, Septic / physiopathology, therapy* Systemic Inflammatory Response Syndrome / therapy |
| Comments/Corrections | |
Erratum In:
|
Curr Opin Anaesthesiol. 2008 Jun;21(3):424 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Arginine vasopressin in vasodilatory shock: effects on metabolism and beyond.
Next Document: Vasopressor use in septic shock: an update.